- Report
- January 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- August 2025
- 377 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 383 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 468 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 372 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 573 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 282 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 278 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 220 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 171 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 276 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 269 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 391 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 376 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- April 2025
- 144 Pages
Global
From €2662EUR$2,999USD£2,291GBP
- Report
- October 2024
- 200 Pages
Global
From €3329EUR$3,750USD£2,865GBP
- Report
- March 2025
- 185 Pages
Global
From €3994EUR$4,500USD£3,438GBP
- Report
- January 2025
- 180 Pages
Global
From €3994EUR$4,500USD£3,438GBP
- Report
- July 2025
- 226 Pages
Global
From €3950EUR$4,450USD£3,400GBP
- Report
- August 2025
- 150 Pages
Global
From €3506EUR$3,950USD£3,018GBP

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus.
Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines.
Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more